Trial Profile
A Pilot, Single-Center, Open-Label Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Non-exudative Age-Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Oct 2014
Price :
$35
*
At a glance
- Drugs MC 1101 (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions
- Sponsors MacuCLEAR
- 29 Oct 2014 New trial record